Get With the Guidelines Atrial Fibrillation Registry

Save

Report Abuse

Description

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Study Overview

Start Date
January 1, 2013
Completion Date
January 1, 2040
Enrollment
17198
Date Posted
February 7, 2024
Accepts Healthy Volunteers?
Yes
Gender
All

Locations

Full Address
Kelly Burlison
Dallas, Texas 75231, United States

Eligibility

Study Population
The study population is patients with the diagnosis of nonvalvular Atrial Fibrillation or Atrial Flutter.
Minimum Age (years)
18
Maximum Age (years)
125
Eligibility Criteria
Inclusion Criteria:

Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion Criteria:

Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter
Patients under 18 years of age
Patients not admitted as inpatients.
Patients on comfort care only
Patients discharged to hospice.

Study Contact Info

Study Contact Name
Kelly Burlison, MPH; Christine Rutan
Study Contact Phone

Contact Listings Owner Form

Get With the Guidelines Atrial Fibrillation Registry 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

Detailed Description
Get With The Guidelines-Atrial Fibrillation was initiated in 2013 with over 88 U.S. hospitals participating is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation:

ACEI/ARB at discharge for LVSD
Assessment of thromboembolic risk factors
Beta Blocker at discharge
Discharged on FDA-approved anticoagulation therapy
PT/INR planned follow-up
Statin at discharge in AF patients with CAD, CVA/TIA or PVD.

Quality measures tracked through Get With The Guidelines-Atrial Fibrillation:

Aldosterone antagonist at discharge
Atrial fibrillation patient education
Anticoagulation therapy education
CHA2DS2-VASC reported
Discharge heart rate <110bpm
Smoking cessation
Warfarin at discharge for valvular atrial fibrillation

Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloadable/ucm_451183.pdf
NCTid (if applicable)
NCT06245187